X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-23 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.11 | -1,126 | 413,864 | 0% | -$22,643 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $91.38 | -787 | 205,552 | 0% | -$71,915 | |||||
2024-04-23 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $91.38 | -531 | 117,029 | 0% | -$48,522 | ||||||
2024-04-23 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $91.38 | -522 | 111,677 | 0% | -$47,700 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $91.38 | -2,552 | 230,319 | -1% | -$233,200 | |||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $91.38 | -1,523 | 73,039 | -2% | -$139,171 | |||||
2024-04-16 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.82 | -80,000 | 117,560 | -40% | -$7,265,651 | ||||||
2024-04-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.13 | -6,816 | 227,710 | -3% | -$634,797 | ||||||
2024-04-12 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.35 | -5,210 | 414,990 | -1% | -$106,024 | ||||||
2024-04-08 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.45 | -2,400 | 83,063 | -3% | -$49,087 | ||||||
| M | 2024-04-04 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $21.12 | -20,923 | 85,463 | -20% | -$441,853 | |||||
2024-04-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.70 | -6,336 | 420,200 | -1% | -$137,491 | ||||||
2024-04-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $92.47 | -26,700 | 460,195 | -5% | -$2,468,822 | ||||||
2024-04-02 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $92.62 | -1,378 | 70,646 | -2% | -$127,629 | ||||||
2024-04-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $70.00 | -2,000 | 77,513 | -3% | -$140,000 | ||||||
2024-04-02 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM., Precision Oncology | S - Sale | $79.43 | -924 | 13,625 | -6% | -$73,393 | ||||||
2024-04-01 | LH | Laboratory Corp of America Holdings | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale | $217.29 | -6,477 | 5,036 | -56% | -$1,407,387 | ||||||
2024-04-01 | LH | Laboratory Corp of America Holdings | Summy Amy B. | EVP, CMO | S - Sale | $217.29 | -3,500 | 3,975 | -47% | -$760,515 | ||||||
| D | 2024-04-01 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $21.65 | -10,000 | 33,125 | -23% | -$216,528 | |||||
2024-03-28 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $70.00 | -2,000 | 79,513 | -2% | -$140,000 | ||||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $90.16 | -1,447 | 486,895 | 0% | -$130,456 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $90.42 | -743 | 204,839 | 0% | -$67,179 | |||||
2024-03-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.42 | -707 | 197,560 | 0% | -$63,924 | ||||||
2024-03-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $90.42 | -464 | 112,199 | 0% | -$41,953 | ||||||
| DM | 2024-03-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $89.09 | -53,572 | 234,526 | -19% | -$4,772,752 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $90.42 | -914 | 72,024 | -1% | -$82,640 | |||||
| D | 2024-03-28 | LH | Laboratory Corp of America Holdings | Van Der Vaart Sandra D | EVP, GC | S - Sale+OE | $216.74 | -3,553 | 7,637 | -32% | -$770,077 | |||||
| DM | 2024-03-27 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $9.44 | -77,136 | 139,771 | -36% | -$727,853 | |||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $9.37 | -38,899 | 908,104 | -4% | -$364,484 | ||||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.37 | -8,092 | 322,488 | -2% | -$75,822 | ||||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.55 | -21,438 | 143,524 | -13% | -$204,733 | ||||||
2024-03-25 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.10 | -22,163 | 164,962 | -12% | -$201,683 | ||||||
| M | 2024-03-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.28 | -6,336 | 426,536 | -1% | -$128,514 | |||||
2024-03-18 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | P - Purchase | $17.82 | +2,187 | 12,722 | +21% | +$38,963 | ||||||
| D | 2024-03-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $88.96 | -83,223 | 282,914 | -23% | -$7,403,534 | |||||
2024-03-07 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.77 | -6,368 | 432,872 | -1% | -$132,263 | ||||||
| D | 2024-03-07 | LH | Laboratory Corp of America Holdings | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale+OE | $218.45 | -5,048 | 5,036 | -50% | -$1,102,736 | |||||
2024-03-07 | LH | Laboratory Corp of America Holdings | Summy Amy B. | EVP, CMO | S - Sale | $218.45 | -227 | 3,859 | -6% | -$49,588 | ||||||
| M | 2024-03-05 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $88.64 | -6,028 | 487,895 | -1% | -$534,331 | |||||
2024-03-05 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $88.37 | -2,160 | 204,218 | -1% | -$190,868 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $88.37 | -9,326 | 297,867 | -3% | -$824,092 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $88.37 | -2,826 | 70,646 | -4% | -$249,719 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $88.36 | -2,245 | 198,267 | -1% | -$198,361 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $88.36 | -1,838 | 112,663 | -2% | -$162,400 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $87.40 | -191,012 | 1,935,684 | -9% | -$16,694,485 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.02 | -1,664 | 187,125 | -1% | -$15,009 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.02 | -444 | 330,580 | 0% | -$4,005 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $9.02 | -1,028 | 159,038 | -1% | -$9,273 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $9.02 | -2,138 | 145,697 | -1% | -$19,285 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $9.02 | -1,856 | 150,179 | -1% | -$16,741 | ||||||
| D | 2024-03-05 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale+OE | $21.41 | -4,131 | 439,240 | -1% | -$88,461 | |||||
2024-03-04 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.68 | -23,323 | 106,386 | -18% | -$482,285 | ||||||
2024-03-04 | XGN | Exagen Inc. | Adawi Kamal | CFO, Corporate Secretary | S - Sale | $1.91 | -12,784 | 243,749 | -5% | -$24,407 | ||||||
| D | 2024-03-04 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $19.05 | -100 | 4,521 | -2% | -$1,905 | |||||
| D | 2024-03-01 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale+OE | $24.36 | -10,000 | 72,774 | -12% | -$243,599 | |||||
2024-03-01 | PSNL | Personalis, Inc. | Myers Woodrow A Jr | Dir | P - Purchase | $1.67 | +10,000 | 26,116 | +62% | +$16,700 | ||||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale+OE | $59.32 | -2,154 | 15,441 | -12% | -$127,775 | |||||
2024-03-01 | EXAS | Exact Sciences Corp | Levangie Daniel J | Dir | S - Sale | $57.50 | -5,000 | 22,975 | -18% | -$287,500 | ||||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Herriott James | GC | S - Sale+OE | $59.32 | -862 | 10,308 | -8% | -$51,134 | |||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale+OE | $59.32 | -2,412 | 12,518 | -16% | -$143,080 | |||||
2024-03-01 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $57.50 | -2,000 | 50,110 | -4% | -$115,000 | ||||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Cunningham Everett | Chief Commercial Officer | S - Sale+OE | $59.32 | -2,412 | 46,750 | -5% | -$143,080 | |||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale+OE | $59.32 | -8,271 | 1,392,609 | -1% | -$490,636 | |||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale+OE | $59.32 | -1,724 | 81,513 | -2% | -$102,268 | |||||
| D | 2024-03-01 | EXAS | Exact Sciences Corp | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $59.32 | -2,323 | 14,549 | -14% | -$137,800 | |||||
2024-02-29 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $87.72 | -16,000 | 493,923 | -3% | -$1,403,542 | ||||||
| M | 2024-02-28 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.45 | -6,744 | 72,761 | -8% | -$852,769 | |||||
2024-02-29 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $125.88 | -5,611 | 44,019 | -11% | -$706,313 | ||||||
| DM | 2024-02-27 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $80.21 | -55,833 | 204,218 | -21% | -$4,478,268 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale+OE | $56.89 | -1,879 | 12,871 | -13% | -$106,896 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Herriott James | GC | S - Sale+OE | $56.89 | -784 | 9,280 | -8% | -$44,602 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Cunningham Everett | Chief Commercial Officer | S - Sale+OE | $56.89 | -3,648 | 43,871 | -8% | -$207,535 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale+OE | $56.89 | -2,710 | 9,639 | -22% | -$154,172 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale+OE | $56.89 | -6,263 | 1,382,737 | 0% | -$356,302 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale+OE | $56.89 | -1,880 | 79,458 | -2% | -$106,953 | |||||
| D | 2024-02-27 | EXAS | Exact Sciences Corp | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $56.89 | -2,027 | 12,148 | -14% | -$115,316 | |||||
2024-02-23 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $59.72 | -1,021 | 77,384 | -1% | -$60,974 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale | $59.78 | -1,013 | 10,796 | -9% | -$60,557 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Herriott James | GC | S - Sale | $59.78 | -291 | 8,416 | -3% | -$17,396 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale | $59.78 | -1,351 | 6,648 | -17% | -$80,763 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Cunningham Everett | Chief Commercial Officer | S - Sale | $59.78 | -1,350 | 39,841 | -3% | -$80,703 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Coward D Scott | Dir | S - Sale | $59.78 | -663 | 49,187 | -1% | -$39,634 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale | $59.78 | -11,565 | 1,334,542 | -1% | -$691,356 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $59.78 | -1,013 | 78,405 | -1% | -$60,557 | ||||||
2024-02-22 | EXAS | Exact Sciences Corp | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale | $59.78 | -1,093 | 10,221 | -10% | -$65,340 | ||||||
| D | 2024-02-21 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $14.15 | -350 | 8,081 | -4% | -$4,953 | |||||
2024-02-22 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $126.14 | -661 | 45,747 | -1% | -$83,379 | ||||||
2024-02-23 | DGX | Quest Diagnostics Inc | Gregg Vicky B | Dir | S - Sale | $126.64 | -2,500 | 16,329 | -13% | -$316,597 | ||||||
2024-02-22 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.14 | -821 | 75,149 | -1% | -$103,561 | ||||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale+OE | $61.50 | -1,078 | 9,775 | -10% | -$66,297 | |||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Herriott James | GC | S - Sale+OE | $61.50 | -415 | 8,126 | -5% | -$25,523 | |||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale+OE | $61.50 | -1,493 | 5,288 | -22% | -$91,820 | |||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Coward D Scott | Dir | S - Sale+OE | $61.50 | -706 | 47,816 | -1% | -$43,419 | |||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale+OE | $61.50 | -4,975 | 1,322,869 | 0% | -$305,963 | |||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale+OE | $61.50 | -1,079 | 77,384 | -1% | -$66,359 | |||||
| D | 2024-02-21 | EXAS | Exact Sciences Corp | Baranick Brian | Gen. Mgr., Precision Oncology | S - Sale+OE | $61.50 | -895 | 9,280 | -9% | -$55,043 | |||||
| D | 2024-02-21 | LH | Laboratory Corp of America Holdings | Eisenberg Glenn A | CFO, EVP | S - Sale+OE | $215.97 | -34,504 | 23,595 | -59% | -$7,451,866 | |||||
2024-02-21 | LH | Laboratory Corp of America Holdings | Divincenzo Jonathan P. | EVP, Pres, Central Labs, Intl | S - Sale | $215.49 | -500 | 3,401 | -13% | -$107,745 | ||||||
| D | 2024-02-16 | NTRA | Natera, Inc. | Rosenman Herm | Dir | S - Sale+OE | $69.37 | -93,901 | 61,685 | -60% | -$6,514,371 | |||||
| D | 2024-02-15 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale+OE | $61.43 | -966 | 8,303 | -10% | -$59,341 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |